Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZDHHC16 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RRP7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MMAB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNURF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CDYL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIF1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRP12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C12orf65 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SNX5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHX30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMIM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PWP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TONSL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NAGA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C20orf27 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANAPC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RITA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on